Effect of nitric oxide on contractions of uterine and cervical tissues from pregnant rats

T. Okawa, Y. P. Vedernikov, George Saade, R. E. Garfield

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Our objective was to evaluate the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway in rat uterine and cervical contractility at mid- and late gestation. Rings of uterus and cervix from Sprague Dawley rats on day 14 of pregnancy (mid-) and day 21 of pregnancy (late) were equilibrated at 2 g passive tension in organ chambers filled with Krebs-Henseleit solution and bubbled with 5% CO2 in air (37°C, pH approximately 7.4). Rings were treated with an inhibitor of outward potassium current, tetraethylammonium, to activate phasic contractions, and the concentration-response relationships to diethylamine/NO and 8-bromo-cGMP (8-br-cGMP) were assessed. Baseline spontaneous activity was significantly higher at term gestation in both uterine and cervical rings compared with mid-gestation. Spontaneous contractile activity was not apparent in cervical rings from rats in mid-gestation, but was persistent after treatment with tetraethylammonium. Oxyhemoglobin did not affect NO-induced inhibition of activation by tetraethylammonium contractile activity in either cervical or uterine tissues in mid- or late gestation. The 8-br-cGMP concentration- dependently inhibited tetraethylammonium-activated contractions that were more pronounced in uterine tissues compared with cervical tissues in both mid- and late gestation. We concluded that activation of the NO-cGMP pathway inhibits both uterine and cervical smooth muscle contractility. Both tissues demonstrated refractoriness to NO at term.

Original languageEnglish (US)
Pages (from-to)186-193
Number of pages8
JournalGynecological Endocrinology
Volume18
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Uterine Contraction
Nitric Oxide
Pregnancy
Tetraethylammonium
Cyclic GMP
Oxyhemoglobins
Cervix Uteri
Smooth Muscle
Sprague Dawley Rats
Potassium
Air

Keywords

  • Cervix
  • Contraction
  • Nitric Oxide
  • Pregnancy
  • Uterus

ASJC Scopus subject areas

  • Endocrinology
  • Obstetrics and Gynecology

Cite this

Effect of nitric oxide on contractions of uterine and cervical tissues from pregnant rats. / Okawa, T.; Vedernikov, Y. P.; Saade, George; Garfield, R. E.

In: Gynecological Endocrinology, Vol. 18, No. 4, 04.2004, p. 186-193.

Research output: Contribution to journalArticle

Okawa, T. ; Vedernikov, Y. P. ; Saade, George ; Garfield, R. E. / Effect of nitric oxide on contractions of uterine and cervical tissues from pregnant rats. In: Gynecological Endocrinology. 2004 ; Vol. 18, No. 4. pp. 186-193.
@article{c311f6fa074d4b0fa9987146cb42c10e,
title = "Effect of nitric oxide on contractions of uterine and cervical tissues from pregnant rats",
abstract = "Our objective was to evaluate the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway in rat uterine and cervical contractility at mid- and late gestation. Rings of uterus and cervix from Sprague Dawley rats on day 14 of pregnancy (mid-) and day 21 of pregnancy (late) were equilibrated at 2 g passive tension in organ chambers filled with Krebs-Henseleit solution and bubbled with 5{\%} CO2 in air (37°C, pH approximately 7.4). Rings were treated with an inhibitor of outward potassium current, tetraethylammonium, to activate phasic contractions, and the concentration-response relationships to diethylamine/NO and 8-bromo-cGMP (8-br-cGMP) were assessed. Baseline spontaneous activity was significantly higher at term gestation in both uterine and cervical rings compared with mid-gestation. Spontaneous contractile activity was not apparent in cervical rings from rats in mid-gestation, but was persistent after treatment with tetraethylammonium. Oxyhemoglobin did not affect NO-induced inhibition of activation by tetraethylammonium contractile activity in either cervical or uterine tissues in mid- or late gestation. The 8-br-cGMP concentration- dependently inhibited tetraethylammonium-activated contractions that were more pronounced in uterine tissues compared with cervical tissues in both mid- and late gestation. We concluded that activation of the NO-cGMP pathway inhibits both uterine and cervical smooth muscle contractility. Both tissues demonstrated refractoriness to NO at term.",
keywords = "Cervix, Contraction, Nitric Oxide, Pregnancy, Uterus",
author = "T. Okawa and Vedernikov, {Y. P.} and George Saade and Garfield, {R. E.}",
year = "2004",
month = "4",
doi = "10.1080/0951359042000196286",
language = "English (US)",
volume = "18",
pages = "186--193",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Effect of nitric oxide on contractions of uterine and cervical tissues from pregnant rats

AU - Okawa, T.

AU - Vedernikov, Y. P.

AU - Saade, George

AU - Garfield, R. E.

PY - 2004/4

Y1 - 2004/4

N2 - Our objective was to evaluate the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway in rat uterine and cervical contractility at mid- and late gestation. Rings of uterus and cervix from Sprague Dawley rats on day 14 of pregnancy (mid-) and day 21 of pregnancy (late) were equilibrated at 2 g passive tension in organ chambers filled with Krebs-Henseleit solution and bubbled with 5% CO2 in air (37°C, pH approximately 7.4). Rings were treated with an inhibitor of outward potassium current, tetraethylammonium, to activate phasic contractions, and the concentration-response relationships to diethylamine/NO and 8-bromo-cGMP (8-br-cGMP) were assessed. Baseline spontaneous activity was significantly higher at term gestation in both uterine and cervical rings compared with mid-gestation. Spontaneous contractile activity was not apparent in cervical rings from rats in mid-gestation, but was persistent after treatment with tetraethylammonium. Oxyhemoglobin did not affect NO-induced inhibition of activation by tetraethylammonium contractile activity in either cervical or uterine tissues in mid- or late gestation. The 8-br-cGMP concentration- dependently inhibited tetraethylammonium-activated contractions that were more pronounced in uterine tissues compared with cervical tissues in both mid- and late gestation. We concluded that activation of the NO-cGMP pathway inhibits both uterine and cervical smooth muscle contractility. Both tissues demonstrated refractoriness to NO at term.

AB - Our objective was to evaluate the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway in rat uterine and cervical contractility at mid- and late gestation. Rings of uterus and cervix from Sprague Dawley rats on day 14 of pregnancy (mid-) and day 21 of pregnancy (late) were equilibrated at 2 g passive tension in organ chambers filled with Krebs-Henseleit solution and bubbled with 5% CO2 in air (37°C, pH approximately 7.4). Rings were treated with an inhibitor of outward potassium current, tetraethylammonium, to activate phasic contractions, and the concentration-response relationships to diethylamine/NO and 8-bromo-cGMP (8-br-cGMP) were assessed. Baseline spontaneous activity was significantly higher at term gestation in both uterine and cervical rings compared with mid-gestation. Spontaneous contractile activity was not apparent in cervical rings from rats in mid-gestation, but was persistent after treatment with tetraethylammonium. Oxyhemoglobin did not affect NO-induced inhibition of activation by tetraethylammonium contractile activity in either cervical or uterine tissues in mid- or late gestation. The 8-br-cGMP concentration- dependently inhibited tetraethylammonium-activated contractions that were more pronounced in uterine tissues compared with cervical tissues in both mid- and late gestation. We concluded that activation of the NO-cGMP pathway inhibits both uterine and cervical smooth muscle contractility. Both tissues demonstrated refractoriness to NO at term.

KW - Cervix

KW - Contraction

KW - Nitric Oxide

KW - Pregnancy

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=1942505328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942505328&partnerID=8YFLogxK

U2 - 10.1080/0951359042000196286

DO - 10.1080/0951359042000196286

M3 - Article

VL - 18

SP - 186

EP - 193

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 4

ER -